Nordic Life Science 1
NASAL DRUG DELIVERY // R&D Maria Alriksson, CEO,
Abera Bioscience Nikolaj Sørensen, CEO, Orexo “We are using a powder so we can achieve higher stability and a longer shelf life, and less sensitivity to temperature variations,” says Nikolaj Sørensen, CEO, Orexo. NORDICLIFESCIENCE.ORG | 77 PHOTO OREXO PHOTO JENNY LAGERQVIST PHOTO JESSYCA